(Q43554481)

English

Can inclusion of serum creatinine values improve the Child-Turcotte-Pugh score and challenge the prognostic yield of the model for end-stage liver disease score in the short-term prognostic assessment of cirrhotic patients?

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

24 November 2017

Can inclusion of serum creatinine values improve the Child-Turcotte-Pugh score and challenge the prognostic yield of the model for end-stage liver disease score in the short-term prognostic assessment of cirrhotic patients? (English)

1 reference

Europe PubMed Central

24 November 2017

liver cirrhosis

0 references

end-stage liver disease

1 reference

based on heuristic

inferred from title

Edoardo G. Giannini

1

1 reference

Europe PubMed Central

24 November 2017

author name string

Federica Botta

2

1 reference

Europe PubMed Central

24 November 2017

Alessandra Fumagalli

3

1 reference

Europe PubMed Central

24 November 2017

Federica Malfatti

4

1 reference

Europe PubMed Central

24 November 2017

Emanuela Testa

5

1 reference

Europe PubMed Central

24 November 2017

Bruno Chiarbonello

6

1 reference

Europe PubMed Central

24 November 2017

Simone Polegato

7

1 reference

Europe PubMed Central

24 November 2017

Michele Bellotti

8

1 reference

Europe PubMed Central

24 November 2017

Sara Milazzo

9

1 reference

Europe PubMed Central

24 November 2017

Giacomo Borgonovo

10

1 reference

Europe PubMed Central

24 November 2017

Roberto Testa

11

1 reference

Europe PubMed Central

24 November 2017

publication date

1 October 2004

1 reference

Europe PubMed Central

24 November 2017

Liver International

1 reference

Europe PubMed Central

24 November 2017

24

1 reference

Europe PubMed Central

24 November 2017

5

1 reference

Europe PubMed Central

24 November 2017

465-470

1 reference

Europe PubMed Central

24 November 2017

A model to predict poor survival in patients undergoing transjugular intrahepatic portosystemic shunts

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2004.0949.X

21 January 2018

A model to predict survival in patients with end-stage liver disease

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2004.0949.X

21 January 2018

MELD scoring system is useful for predicting prognosis in patients with liver cirrhosis and is correlated with residual liver function: a European study.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2004.0949.X

21 January 2018

Model for end-stage liver disease (MELD) and allocation of donor livers

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2004.0949.X

21 January 2018

Child-Pugh versus MELD score in predicting survival in patients undergoing transjugular intrahepatic portosystemic shunt

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2004.0949.X

21 January 2018

Gene therapy for hepatocellular carcinoma-teaching old dogs new tricks.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2004.0949.X

21 January 2018

Utility of the Mayo End-Stage Liver Disease (MELD) score in assessing prognosis of patients with alcoholic hepatitis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2004.0949.X

21 January 2018

Is MELD really the definitive score for liver allocation?

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2004.0949.X

21 January 2018

The new liver allocation system: moving toward evidence-based transplantation policy

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2004.0949.X

21 January 2018

MELD: the end of Child-Pugh classification?

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2004.0949.X

21 January 2018

A prognostic model for predicting survival in cirrhosis with ascites.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2004.0949.X

21 January 2018

MELD: the answer or just more questions?

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2004.0949.X

21 January 2018

The North American Study for the Treatment of Refractory Ascites

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2004.0949.X

21 January 2018

The 1-year and 3-month prognostic utility of the AST/ALT ratio and model for end-stage liver disease score in patients with viral liver cirrhosis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2004.0949.X

21 January 2018

Hepatic encephalopathy--definition, nomenclature, diagnosis, and quantification: final report of the working party at the 11th World Congresses of Gastroenterology, Vienna, 1998.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2004.0949.X

21 January 2018

Model for end-stage liver disease and Child-Turcotte-Pugh score as predictors of pretransplantation disease severity, posttransplantation outcome, and resource utilization in United Network for Organ Sharing status 2A patients

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2004.0949.X

21 January 2018

Identifiers

10.1111/J.1478-3231.2004.0949.X

1 reference

Europe PubMed Central

24 November 2017

release_j5k5oqjn7vfmda472w6w5cng7i

1 reference

https://api.fatcat.wiki/v0/release/j5k5oqjn7vfmda472w6w5cng7i

24 November 2022

based on heuristic

mapped directly with Wikidata item

1 reference

Europe PubMed Central

24 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43554481&oldid=2100735978"